&nbsp;

Jan 2025

Drug

pegfilgrastim

Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™

Quick Link(s):

Sep 2025

Drug

pegylated liposomal DOXOrubicin

Other Name(s): Caelyx®

Quick Link(s):

Sep 2025

Drug

brentuximab vedotin

Other Name(s): Adcetris®

Quick Link(s):

Jun 2025

Drug

pomalidomide

Other Name(s): Pomalyst®

Quick Link(s):

Apr 2025

Drug

pembrolizumab

Other Name(s): Keytruda®

Quick Link(s):

Sep 2025

Drug

blinatumomab

Other Name(s): Blincyto®

Quick Link(s):

Nov 2025

Drug

palbociclib

Other Name(s): Ibrance™

Quick Link(s):

Oct 2025

Regimen

BICALPRL

Cancer Type:

Genitourinary,

Prostate

Intent: Neoadjuvant, Adjuvant, Palliative

Funding:

ODB - General Benefit

leuprolide - long-acting formulation

ODB - General Benefit

bicalutamide

, Collapse Show fewer tags

Drugs Used:

leuprolide,

bicalutamide

... Show more tags

Quick Link(s):

Regimen Monograph

May 2025

Regimen

PGLDX

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Funding:

New Drug Funding Program

Liposomal DOXOrubicin - Single Agent Treatment of Platinum Sensitive Ovarian Fallopian Tube or Primary Peritoneal Cancer

New Drug Funding Program

Liposomal Doxorubicin - Platinum-Resistant Ovarian Fallopian Tube or Primary Peritoneal Cancer